Veracyte is a global genomic diagnostics company dedicated to improving patient care by providing critical answers to clinical questions that inform diagnosis and treatment decisions in cancer and other diseases. With a focus on leveraging advances in genomic science and technology, Veracyte's growing portfolio of genomic tests helps patients avoid unnecessary diagnostic procedures and accelerates their access to appropriate treatments. The company offers tests for various cancers, including lung, prostate, breast, thyroid, and bladder cancer, and is committed to delivering innovative solutions to patients worldwide. Based in South San Francisco, California, Veracyte is recognized for its inclusive workplace culture and is a Certified Great Place to Work in both the US and Israel.